Quantitative structure-activity relationships for calmodulin inhibitors. 1990

Q Liu, and S Hirono, and I Moriguchi
School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan.

Using the discriminant analysis method, we completely distinguished 24 calmodulin inhibitors in three groups, as classified by Zimmer et al. The resultant discriminant functions distinguished the three groups in terms of positive potential surface area on the side chain, as well as the total and neutral surface areas on the ring in the inhibitor molecules. Group assignment of additional calmodulin inhibitors from other sources was then estimated according to the discriminant functions. The relationship between structure and inhibitory potency on calmodulin-activated phosphodiesterase for group I inhibitors, together with those estimated, was studied using the adaptive least squares method with several parameters dependent on molecular conformations. A "best conformer" was selected for each inhibitor on the basis of quantitative structure-activity relationship (QSAR). The results of QSAR analysis of group I inhibitors showed that hydrophobicity was important for the ring moiety but not for the side chain. The negative potential surface area of the side chain is necessary for activity. It is desirable for the nitrogen atom in the side chain, which is considered the center of the negative potential area, to be located far from the ring moiety. Thus, the ring moiety and side chain may possibly play different roles in interactions with the receptor system.

UI MeSH Term Description Entries
D002147 Calmodulin A heat-stable, low-molecular-weight activator protein found mainly in the brain and heart. The binding of calcium ions to this protein allows this protein to bind to cyclic nucleotide phosphodiesterases and to adenyl cyclase with subsequent activation. Thereby this protein modulates cyclic AMP and cyclic GMP levels. Calcium-Dependent Activator Protein,Calcium-Dependent Regulator,Bovine Activator Protein,Cyclic AMP-Phosphodiesterase Activator,Phosphodiesterase Activating Factor,Phosphodiesterase Activator Protein,Phosphodiesterase Protein Activator,Regulator, Calcium-Dependent,AMP-Phosphodiesterase Activator, Cyclic,Activating Factor, Phosphodiesterase,Activator Protein, Bovine,Activator Protein, Calcium-Dependent,Activator Protein, Phosphodiesterase,Activator, Cyclic AMP-Phosphodiesterase,Activator, Phosphodiesterase Protein,Calcium Dependent Activator Protein,Calcium Dependent Regulator,Cyclic AMP Phosphodiesterase Activator,Factor, Phosphodiesterase Activating,Protein Activator, Phosphodiesterase,Protein, Bovine Activator,Protein, Calcium-Dependent Activator,Protein, Phosphodiesterase Activator,Regulator, Calcium Dependent
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Q Liu, and S Hirono, and I Moriguchi
June 2003, Mini reviews in medicinal chemistry,
Q Liu, and S Hirono, and I Moriguchi
January 2003, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques,
Q Liu, and S Hirono, and I Moriguchi
March 2008, Medicinal chemistry (Shariqah (United Arab Emirates)),
Q Liu, and S Hirono, and I Moriguchi
August 2003, Mini reviews in medicinal chemistry,
Q Liu, and S Hirono, and I Moriguchi
January 1999, Journal of enzyme inhibition,
Q Liu, and S Hirono, and I Moriguchi
April 1990, Ecotoxicology and environmental safety,
Q Liu, and S Hirono, and I Moriguchi
January 1989, Toxicology in vitro : an international journal published in association with BIBRA,
Q Liu, and S Hirono, and I Moriguchi
January 1979, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques,
Q Liu, and S Hirono, and I Moriguchi
March 1995, Bioorganic & medicinal chemistry,
Q Liu, and S Hirono, and I Moriguchi
March 1990, Journal of medicinal chemistry,
Copied contents to your clipboard!